Influence of Lisdexamfetamine Dimesylate on Early Ejaculation-Results from a Double-Blind Randomized Clinical Trial - PubMed
- ️Fri Jan 01 2021
Influence of Lisdexamfetamine Dimesylate on Early Ejaculation-Results from a Double-Blind Randomized Clinical Trial
Mohammad Haghighi et al. Healthcare (Basel). 2021.
Abstract
Background: Among male sexual dysfunctions, erectile dysfunction and early ejaculation have the highest prevalence rates. Here, we tested the influence of lisdexamfetamine dimesylate (Vyas®) on early ejaculation. To this end, we performed a double-blind randomized clinical trial among males with early ejaculation.
Methods: A total of 46 males with early ejaculation (mean age: 35.23 years) and in stable marital relationships with regular weekly penile-vaginal intercourse were randomly assigned either to the lisdexamfetamine dimesylate condition (30 mg) or to the placebo condition. Compounds were taken about six hours before intended penile-vaginal intercourse. At baseline and four weeks later at the end of the study, participants completed a series of self-rating questionnaires covering early ejaculation. Female partners also rated participants' early ejaculation profile.
Results: Compared to the placebo condition, dimensions of early ejaculation improved over time in the lisdexamfetamine condition, though improvements were also observed in the placebo condition.
Conclusions: Among male adults in stable marital relationships with regular weekly penile-vaginal intercourse, lisdexamfetamine dimesylate improved dimensions of early ejaculation. Given that improvements were also observed in the placebo condition, psychological factors such as increased attention to early ejaculation and favorable expectations of the compound should be considered.
Keywords: double-blind clinical trial; early ejaculation; lisdexamfetamine dimesylate; male sexual dysfunction; placebo.
Conflict of interest statement
All authors declare no conflict of interest.
Similar articles
-
Influence of modafinil on early ejaculation - Results from a double-blind randomized clinical trial.
Haghighi M, Jahangard L, Meybodi AM, Shayganfard M, Ahmadpanah M, Faryadres M, Dürsteler KM, Brühl AB, Sadeghi-Bahmani D, Brand S. Haghighi M, et al. J Psychiatr Res. 2022 Feb;146:264-271. doi: 10.1016/j.jpsychires.2021.11.015. Epub 2021 Nov 9. J Psychiatr Res. 2022. PMID: 34799125 Clinical Trial.
-
Adler LA, Dirks B, Deas PF, Raychaudhuri A, Dauphin MR, Lasser RA, Weisler RH. Adler LA, et al. J Clin Psychiatry. 2013 Jul;74(7):694-702. doi: 10.4088/JCP.12m08144. J Clin Psychiatry. 2013. PMID: 23945447 Clinical Trial.
-
Richards C, Iosifescu DV, Mago R, Sarkis E, Reynolds J, Geibel B, Dauphin M. Richards C, et al. J Psychopharmacol. 2017 Sep;31(9):1190-1203. doi: 10.1177/0269881117722998. Epub 2017 Aug 31. J Psychopharmacol. 2017. PMID: 28857719 Free PMC article. Clinical Trial.
-
Review of Lisdexamfetamine Dimesylate in Adults With Attention-Deficit/Hyperactivity Disorder.
Najib J, Wimer D, Zeng J, Lam KW, Romanyak N, Paige Morgan E, Thadavila A. Najib J, et al. J Cent Nerv Syst Dis. 2017 Aug 23;9:1179573517728090. doi: 10.1177/1179573517728090. eCollection 2017. J Cent Nerv Syst Dis. 2017. PMID: 28855799 Free PMC article. Review.
References
-
- Miller G. The Mating Mind: How Sexual Choice Shaped the Evolution of Human Nature. Heineman; London, UK: 2000.
-
- Buss D.M. Evolutionary Psychology. The New Science of the Mind. 6th ed. Routledge; New York, NY, USA: 2019.
LinkOut - more resources
Full Text Sources